Immunome, Inc.

United States, Bothell

Report a bug?

Claim ownership and edit

Description

Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Industries

Wood Product Manufacturing

SIC

Lumber and Wood Products, Except Furniture

Address:

18702 North Creek Parkway

Website:

immunome.com

Revenue

Recent news:

ENAVATE Sciences Expands Zenas BioPharma Stake to $142.3M

ENAVATE Sciences significantly increased its investment in Zenas BioPharma, making it the firm's largest portfolio holding at 28.08% of its reportable assets, as detailed in a recent SEC filing.

Source: IndexBox Mar 21, 2026

XNAS - Delayed Quote - USD

IMNM

20.01 -0.82 (-3.94%)

At close March 23 02:32 UTC

Candle

Line

Financial Statistics

Valuation Measures

Current

Quarterly

As of 06/22/2025

Market Cap: 760.05 M

Enterprise Value: 447.50 M

Trailing P/E: N/A

Forward P/E: -3.02

PEG Ratio (5yr expected): N/A

Price/Sales (ttm): 52.39

Price/Book (mrq): 2.47

Enterprise Value/Revenue: 40.91

Enterprise Value/EBITDA: -2.55

Financial Highlights

Profitability and Income Statement

Profit Margin: N/A%

Return on Assets (ttm): -33.54%

Return on Equity (ttm): -69.21%

Revenue (ttm): 10.94 M

Net Income Avi to Common (ttm): -205.11 M

Diluted EPS (ttm): -3.01

Balance Sheet and Cash Flow

Total Cash (mrq): 317.32 M

Total Debt/Equity (mrq): 1.55%

Levered Free Cash Flow (ttm): -117.16 M

Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.